Our new Cotinine EIA Kit is an efficient, highly accurate, and cost-effective means of quantitatively monitoring nicotine exposure. The kit is designed specifically for studying the use of tobacco (or nicotine products) in population-based and national surveys,
New Salivary Enzyme Immunoassay Quantitatively Measures Cotinine, A Metabolite of Nicotine Table 1: Salivary cotinine levels (ng/ml) in smoking and nonsmoking mothers and their six month-old infants. Salimetrics' quantitative enzyme immunoassay for salivary cotinine discriminates smokers from non-smokers, and differentiates primary- from secondary-smoke exposure Mother's Self-Reported Status: Smokers (n=27) Group Mean
Standard
Number of cigarettes smoked in Mother's salivary cotinine (ng/ml) Infant salivary cotinine (ng/ml)
14.67
14.26
3-60 Ranges Mother's Self-Reported Status: Non-smokers (n=20) Group Mean
Standard
Number of cigarettes smoked in Mother's salivary cotinine (ng/ml) Infant salivary cotinine (ng/ml)
NA
0.0 Ranges
NA Notes:
1. Smoking status determined by number of cigarettes smoked in the past 48 hours, “0” = non-smoker, “> 3” smoker.
3.
Only one infant of a smoking mother had received breast milk in prior seven days.
Data from: Granger, D. A., Blair, C ., Willoughby , M., Kivlighan, K. T. and The Family Life Project Investigators (2005). Salivary cotinine levels in mothers and their six-month old infants. Unpublished Technical Report. Figure 1. Positive association between mother and infant salivary cotinine (ng/ml) Figure 2. Positive association between number of cigarettes smoked in the past 48 hours and salivary cotinine (ng/ml) in mothers
Copyright 2005 Salimetrics LLC |